CAMBRIDGE, Mass.–(BUSINESS WIRE)– Ra
Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage
biopharmaceutical company focusing on the development of next-generation
therapeutics for the treatment of complement-mediated diseases, today
announced that Doug Treco, Ph.D., President and Chief Executive Officer,
will present at the Cantor Fitzgerald Global Healthcare Conference
on Wednesday, September 27, 2017 at 10:55 a.m. E.T. The conference is
being held at the InterContinental New York Barclay Hotel.
The presentation will be webcast live and can be accessed by visiting
the investor relations section of the Company’s website, www.rapharma.com.
A replay of the presentation will also be available and archived on the
site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company
focusing on the development of next-generation therapeutics for
complement-mediated diseases. The Company discovers and develops
peptides and small molecules to target key components of the complement
cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170920005320/en/
Contacts
Investors:
Ra Pharmaceuticals, Inc.
Jennifer Robinson,
617-674-9873
jrobinson@rapharma.com
or
Media:
Argot
Partners
Eliza Schleifstein, 917-763-8106
eliza@argotpartners.com
Source: Ra Pharmaceuticals, Inc.
Cet article Ra Pharmaceuticals to Present at the Cantor Fitzgerald Global
Healthcare Conference est apparu en premier sur EEI-BIOTECHFINANCES.